Breathe BioMedical
PrivateLast Round
IPO
Oct 28, 2024
Total Funding Raised
$1.02M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Breathe BioMedical is a medical technology company that is developing a breath analytics platform for the early detection of diseases, with an initial focus on breast cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Breathe BioMedical Comparables
Compare Breathe BioMedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Menssana Research Inc. | 78% | |
| Owlstone Medical | 77% | |
| Breath Diagnostics | 76% |
Breathe BioMedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Oct 28, 2024 | ||||
| VC Round | Jun 9, 2022 | ||||
| VC Round | Jun 9, 2022 | ||||
| Grant | Feb 4, 2022 | ||||
| Grant | May 29, 2019 | ||||
Grant | Feb 12, 2019 |
Key People
Founding team and executive leadership
Breathe BioMedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Brunswick Innovation Foundation | VC Round, Grant |
| Atlantic Canada Opportunities Agency | VC Round, Grant |
| Maxim Group | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 8, 2026
Open roles increased to 39, 139% of headcount.
- Jul 20, 2026
Open roles increased to 39, 139% of current headcount.
Recent news
Latest coverage and updates
- is_developingJul 22, 2026
Breathe BioMedical Inc. is developing breath analytics platform.
Breathe BioMedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Breathe BioMedical's valuation, stock price, and market status.
Is Breathe BioMedical a public or private company?
Breathe BioMedical is a private company.
What is the current stock price of Breathe BioMedical?
Breathe BioMedical is a private company with no public stock price. No recent secondary market data is available.
How much is Breathe BioMedical worth (valuation)?
Valuation information for Breathe BioMedical is not publicly available.
Can I buy Breathe BioMedical stock?
Breathe BioMedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Breathe BioMedical's last funding round?
Breathe BioMedical's most recent funding round was IPO on October 28, 2024.
Who are the main investors in Breathe BioMedical?
Key investors in Breathe BioMedical include Maxim Group.
Will Breathe BioMedical IPO soon?
No public IPO plans have been announced for Breathe BioMedical.
How can I track Breathe BioMedical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Breathe BioMedical's secondary market activity and sign up for updates.